14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:DXTR
Delisted

Dextera Surgical Fund Forecast

$0.0499
+0 (+0%)
At Close: May 31, 2018
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Dextera Surgical fund price ended at $0.0499 on Thursday, after losing 0%.
(Updated on May 31, 2018)

Buy or Hold candidate since Apr 27, 2018 Gain 42.57% PDF

No changes to the price of Dextera Surgical fund on the last trading day (Thursday, 31st May 2018). During the last trading day the fund fluctuated 0% from a day low at $0.0499 to a day high of $0.0499. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The fund lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the fund is expected to rise 94.60% during the next 3 months and, with a 90% probability hold a price between $0.0809 and $0.118 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

DXTR Signals & Forecast

The Dextera Surgical fund holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0499 and $0.0427. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 30, 2018, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation

Support, Risk & Stop-loss for Dextera Surgical fund

On the downside, the fund finds support just below today's level from accumulated volume at $0.0389 and $0.0380. There is a natural risk involved when a fund is testing a support level, since if this is broken, the fund then may fall to the next support level. In this case, Dextera Surgical finds support just below today's level at $0.0389. If this is broken, then the next support from accumulated volume will be at $0.0380 and $0.0379.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0 between high and low, or 0%. For the last week the fund has had daily average volatility of 0%

Our recommended stop-loss: $0.0479 (-4.00%) (This fund has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (DXTR) For The Upcoming Trading Day Of Friday 1st

For the upcoming trading day on Friday, 1st we expect Dextera Surgical to open at $0.0499, and during the day (based on 14 day Average True Range), to move between $0.0482 and $0.0516, which gives a possible trading interval of +/-$0.0017 (+/-3.34%) up or down from last closing price. If Dextera Surgical takes out the full calculated possible swing range there will be an estimated 6.68% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $0.0389, some $0.0110 (22.04%) from the current price of $0.0499, our system finds the risk reward attractive.

Is Dextera Surgical fund A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Dextera Surgical fund to perform well in the short-term.

Current score: 2.010 Buy Candidate Unchanged

Predicted Opening Price for Dextera Surgical of Friday, June 1, 2018

Fair opening price June 1, 2018 Current price
$0.0499 ( 0%) $0.0499

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for DXTR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0499 .
R2 0.0499 .
R1 0.0499 .
Current price: 0.0499
Support S1 0.0499 .
S2 0.0499 .
S3 0.0499 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 0.0499
Support S1 0.0389 -22.04%
S2 0.0380 -23.85%
S3 0.0379 -24.05%

FAQ

What is the symbol for Dextera Surgical Fund and on which exchange is it traded?
The symbol for Dextera Surgical is DXTR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Dextera Surgical Fund?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Dextera Surgical fund to perform well in the short-term.

How to buy Dextera Surgical Fund?
Dextera Surgical Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Dextera Surgical Fund.

What's the current price of Dextera Surgical Fund?
As of the end of day on the May 31, 2018, the price of an Dextera Surgical (DXTR) share was $0.0499.

What is the 52-week high and low for Dextera Surgical Fund?
The 52-week high for Dextera Surgical Fund is $184.23 and the 52-week low is $127.25.
Click to get the best stock tips daily for free!

About Dextera Surgical

Dextera Surgical Inc. designs, manufactures, and markets automated anastomotic systems for use by cardiac surgeons to perform coronary bypass surgery in the United States and internationally. It offers C-Port xA Anastomosis systems to perform an end-to-side distal anastomosis by attaching the end of a bypass graft to a coronary artery downstream of an occlusion or narrowing; C-Port Flex A Anastomosis systems to enable automated anastomoses to be ... DXTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT